# The Human Medicines Regulations 2012, Regulation 172: Parallel import licences

Extent: E+W+S+N.I.

(1) The prohibitions in regulation 46 (requirement for authorisation) do not prevent—
(a) the holder of a parallel import licence from placing the medicinal product to which the licence relates on the market; or
(b) the sale or supply, or offer for sale or supply, of a medicinal product to which a parallel import licence relates, in accordance with the terms of that licence.
(2) In this regulation “parallel import licence” has the same meaning as in regulation 48(2).

---
Source: https://www.legislation.gov.uk/uksi/2012/1916/regulation/172 (the official version)
Page: https://openlegislation.uk/human-medicines-regulations-2012/regulation-172
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.